Baxter International Inc (BAX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $13.35B
Last updated: Nov 17, 2026 at 11:05 AM ET
Baxter International Inc (BAX) P/E Ratio & Valuation History
Baxter International (BAX) trades at 13.2x trailing earnings and 1.1x sales. Its P/E of 13.2x is below its 5-year median of 13.5x. Its forward P/E is 12.2x. The median P/E across 11 similar companies is 20.7x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 8.2% higher over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 13.2x |
| Forward P/E | 12.2x |
| Price to sales | 1.1x |
| Price to book | 2.0x |
| EV/EBITDA | 19.5x |
| Price to FCF | 11.6x |
| EV/FCF | 17.4x |
| PEG | N/A |
| FCF yield | 8.6% |
Historical Medians
Against its 10-year medians, its P/E is 42.6% below 23.0x, its P/S is 63.3% below 3.0x and its P/B is 48.7% below 3.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 13.2x | 13.5x | 23.0x |
| P/S | 1.1x | 2.0x | 3.0x |
| P/B | 2.0x | 2.4x | 3.9x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 8.4x in 2025 to 26.0x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $19.11 | 8.4x | 0.9x | 1.6x |
| 2024 | $29.16 | 12.2x | 1.4x | 2.1x |
| 2023 | $38.66 | 14.3x | 1.9x | 2.3x |
| 2022 | $50.97 | 14.6x | 2.6x | 4.4x |
| 2021 | $85.84 | 23.7x | 3.6x | 4.8x |
| 2020 | $80.24 | 26.0x | 3.5x | 4.8x |
| 2019 | $83.62 | 24.9x | 3.8x | 5.5x |
| 2018 | $65.82 | 21.6x | 3.2x | 4.5x |
| 2017 | $64.64 | 26.0x | 3.3x | 3.9x |
| 2016 | $44.34 | 22.7x | 2.4x | 2.9x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BAX
What is BAX's forward P/E ratio?
Baxter International has a forward P/E ratio of 12.2x.
Is BAX stock overvalued?
GNG's valuation label for BAX is Undervalued. Its P/E of 13.2x compares with a median of 20.7x across 11 similar companies.
What is BAX's price to sales ratio?
Baxter International has a price to sales ratio of 1.1x.
What is Baxter International's average P/E ratio over 5 years?
Baxter International's median P/E over the last 5 years is 13.5x, from 60 month-end values through Oct 2026.
BAX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors